Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities
In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy
Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL
Columbia Univ. Places cDNA Libraries In Public Domain
New England Medical Center Discloses Case Of Two Overdoses
Komen Foundation Announces Second Grant Cycle For 1995
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









